On Monday, July 8, the next meeting of the Transparency Council.
The agenda includes:
1 Prepare a position paper on the evaluation of the drug Kanuma (sebelipazum alfa) under the drug program "Treatment of patients with lysosomal acid lipase deficiency (ICD-10 E75.5 E75.6)".
2 Prepare a position paper on the evaluation of the drug Keytrud...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
